These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. Witherspoon LR, Lapeyrolerie T. J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931 [Abstract] [Full Text] [Related]
4. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285 [Abstract] [Full Text] [Related]
5. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG. Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764 [Abstract] [Full Text] [Related]
6. Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy. Pruthi RS, Haese A, Huland E, Stamey TA. Urology; 1997 Mar 15; 49(3):404-10. PubMed ID: 9123706 [Abstract] [Full Text] [Related]
7. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG. Urology; 1997 Oct 15; 50(4):573-9. PubMed ID: 9338734 [Abstract] [Full Text] [Related]
12. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. Noguchi M, Stamey TA, Neal JE, Yemoto CE. J Urol; 2000 Jun 15; 163(6):1751-5. PubMed ID: 10799175 [Abstract] [Full Text] [Related]
13. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. Iwakiri J, Granbois K, Wehner N, Graves HC, Stamey T. J Urol; 1993 Apr 15; 149(4):783-6. PubMed ID: 7681118 [Abstract] [Full Text] [Related]
16. Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer. Pruthi RS, Johnstone I, Tu IP, Stamey TA. Urology; 1997 May 15; 49(5):737-42. PubMed ID: 9145980 [Abstract] [Full Text] [Related]
17. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial. Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG. J Urol; 1999 Oct 15; 162(4):1346-51. PubMed ID: 10492194 [Abstract] [Full Text] [Related]
18. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ. Urology; 2004 Oct 15; 64(4):723-8. PubMed ID: 15491709 [Abstract] [Full Text] [Related]